The U.S. and Europe pharmaceutical manufacturing market size is expected to reach USD 641.22 billion by 2030 and is expected to expand at 6.81% CAGR from 2023 to 2030. The presence of supportive regulatory legislation, patentability norms, high investments in the pharmaceutical industry, and increasing healthcare expenditure remain key drivers of growth. In addition, the rising trend of third-party production across the pharmaceutical sector along with the increased emphasis on cost-cutting approaches are likely to provide lucrative growth opportunities.
A continuous increase in the number of clinical trials of pharmaceutical products is expected to create numerous opportunities for market growth in the coming years. According to ClinicalTrials.gov, as of January 2023, a total of 137,145 ongoing clinical studies were registered in the U.S., which accounts for 31% of overall clinical trials. This increase in the number of clinical studies indicates the growth of the pharmaceutical industry, which is likely to create new avenues for market stakeholders.
Moreover, the majority of pharmaceutical manufacturers have shifted their preference toward continuous production approaches to overcome medicines shortages, reduces production cost, and improve manufacturing efficiencies. For instance, in January 2021, CONTINUUS Pharmaceuticals Inc. announced a receipt of USD 69.3 million U.S. government contract to speed up country-level production of three essential medicines to treat severely ill patients. Moreover, this contract helped the company to enable cost-efficient production to facilitate the delivery of high-quality and affordable therapeutics to patients.
Government initiatives to establish domestic pharmaceutical manufacturing sites are one of the determinants of pharmaceutical manufacturing market growth. For instance, in April 2022, CureVac and GSK plc entered into a partnership to be part of the German Pandemic contingency plan to increase mRNA production capacity and the government will receive access to CureVac’s production capacity until 2029.
The UK government is taking action to establish local manufacturing through Medicines Manufacturing Innovation Centre. Under this program, drug makers, academic institutions, healthcare providers, and regulatory bodies are expected to combine their resources at the facility to test and enhance new technologies, including autonomous production.
Furthermore, the organic and inorganic developments undertaken by pharmaceutical companies to strengthen their business avenues are anticipated to support market expansion. For instance, in October 2021, Samsung Biologics and Enzolytics, Inc. signed a development & manufacturing agreement for Anti-SARS-CoV-2 Monoclonal Antibody and Anti-HIV therapies. Similarly, in February 2021, WuXi STA purchased Bristol Myers Squibb’s manufacturing unit in Switzerland. This expansion will further enhance its existing capabilities.
U.S. And Europe Pharmaceutical Manufacturing Market Highlights
- The small molecule segment held the largest share of the market in 2022, owing to the high consumption rate of small molecules and increasing product approvals
- The outsource segment accounted for the largest market share in 2022 due to various benefits associated with outsource manufacturing such as low investment and high manufacturing efficiency
- Based on formulation, the tablets dominated the U.S. & Europe pharmaceutical manufacturing industry in 2022, whereas the sprays segment is anticipated to be the fastest-growing segment
- The oral segment was the largest in 2022 owing to the high availability of top-selling preparations as an oral dosage form and a high demand for oral formulations
- Based on the therapy area, the cancer segment held the largest revenue share of the market. Whereas the respiratory diseases segment is anticipated to grow at an exponential growth rate
- Europe is expected to exhibit the fastest growth during the forecast period due to favorable government policies and ongoing research activities
A continuous increase in the number of clinical trials of pharmaceutical products is expected to create numerous opportunities for market growth in the coming years. According to ClinicalTrials.gov, as of January 2023, a total of 137,145 ongoing clinical studies were registered in the U.S., which accounts for 31% of overall clinical trials. This increase in the number of clinical studies indicates the growth of the pharmaceutical industry, which is likely to create new avenues for market stakeholders.
Moreover, the majority of pharmaceutical manufacturers have shifted their preference toward continuous production approaches to overcome medicines shortages, reduces production cost, and improve manufacturing efficiencies. For instance, in January 2021, CONTINUUS Pharmaceuticals Inc. announced a receipt of USD 69.3 million U.S. government contract to speed up country-level production of three essential medicines to treat severely ill patients. Moreover, this contract helped the company to enable cost-efficient production to facilitate the delivery of high-quality and affordable therapeutics to patients.
Government initiatives to establish domestic pharmaceutical manufacturing sites are one of the determinants of pharmaceutical manufacturing market growth. For instance, in April 2022, CureVac and GSK plc entered into a partnership to be part of the German Pandemic contingency plan to increase mRNA production capacity and the government will receive access to CureVac’s production capacity until 2029.
The UK government is taking action to establish local manufacturing through Medicines Manufacturing Innovation Centre. Under this program, drug makers, academic institutions, healthcare providers, and regulatory bodies are expected to combine their resources at the facility to test and enhance new technologies, including autonomous production.
Furthermore, the organic and inorganic developments undertaken by pharmaceutical companies to strengthen their business avenues are anticipated to support market expansion. For instance, in October 2021, Samsung Biologics and Enzolytics, Inc. signed a development & manufacturing agreement for Anti-SARS-CoV-2 Monoclonal Antibody and Anti-HIV therapies. Similarly, in February 2021, WuXi STA purchased Bristol Myers Squibb’s manufacturing unit in Switzerland. This expansion will further enhance its existing capabilities.
U.S. And Europe Pharmaceutical Manufacturing Market Highlights
- The small molecule segment held the largest share of the market in 2022, owing to the high consumption rate of small molecules and increasing product approvals
- The outsource segment accounted for the largest market share in 2022 due to various benefits associated with outsource manufacturing such as low investment and high manufacturing efficiency
- Based on formulation, the tablets dominated the U.S. & Europe pharmaceutical manufacturing industry in 2022, whereas the sprays segment is anticipated to be the fastest-growing segment
- The oral segment was the largest in 2022 owing to the high availability of top-selling preparations as an oral dosage form and a high demand for oral formulations
- Based on the therapy area, the cancer segment held the largest revenue share of the market. Whereas the respiratory diseases segment is anticipated to grow at an exponential growth rate
- Europe is expected to exhibit the fastest growth during the forecast period due to favorable government policies and ongoing research activities
Table of Contents
Chapter 1 Methodology and Scope1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 U.S. & Europe Pharmaceutical Manufacturing Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Rise in pharmaceutical R&D spending
3.2.1.2 Advancements in pharmaceutical manufacturing technologies
3.2.1.3 Increasing geriatric population and incidence of chronic disorders
3.2.2 Market restraint analysis
3.2.2.1 Challenges pertaining to pharma supply chain
3.2.2.2 Pricing pressures on pharmaceutical companies
3.3 Penetration & Growth Prospect Mapping
3.4 U.S. & Europe Pharmaceutical Manufacturing Market: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Product Type, 2018 - 2030 (USD Billion)
4.1 Definition and Scope
4.2 Product Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Product Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Small Molecule
4.5.1.1 Small molecule market estimates and forecast, 2018 - 2030 (USD Billion)
4.5.2 Large Molecule
4.5.2.1 Large molecule market estimates and forecast, 2018 - 2030 (USD Billion)
4.5.2.1.1 Monoclonal Antibodies
4.5.2.1.1.1 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Billion)
4.5.2.1.2 Vaccines
4.5.2.1.2.1 Vaccines market estimates and forecast, 2018 - 2030 (USD Billion)
4.5.2.1.3 Cell & Gene Therapy
4.5.2.1.3.1 Cell & Gene therapy market estimates and forecast, 2018 - 2030 (USD Billion)
4.5.2.1.4 Others
4.5.2.1.4.1 Others molecule market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 5 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Drug Development Type 2018 - 2030 (USD Billion)
5.1 Definition and Scope
5.2 Drug Development Type Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Drug Development Type, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Outsource
5.5.1.1 Outsource market estimates and forecast, 2018 - 2030 (USD Billion)
5.5.2 In - house
5.5.2.1 In - house market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 6 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Route of Administration, 2018 - 2030 (USD Billion)
6.1 Definition and Scope
6.2 Route of Administration Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Route of Administration, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Oral
6.5.1.1 Oral market estimates and forecast, 2018 - 2030 (USD Billion)
6.5.2 Topical
6.5.2.1 Topical market estimates and forecast, 2018 - 2030 (USD Billion)
6.5.3 Parenterals
6.5.3.1 Parenterals market estimates and forecast, 2018 - 2030 (USD Billion)
6.5.4 Inhalations
6.5.4.1 Inhalations market estimates and forecast, 2018 - 2030 (USD Billion)
6.5.5 Others
6.5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 7 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Formulation, 2018 - 2030 (USD Billion)
7.1 Definition and Scope
7.2 Formulation Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Formulation, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Tablets
7.5.1.1 Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
7.5.2 Capsules
7.5.2.1 Capsules market estimates and forecast, 2018 - 2030 (USD Billion)
7.5.3 Injectables
7.5.3.1 Injectables market estimates and forecast, 2018 - 2030 (USD Billion)
7.5.4 Sprays
7.5.4.1 Sprays market estimates and forecast, 2018 - 2030 (USD Billion)
7.5.5 Suspensions
7.5.5.1 Suspensions market estimates and forecast, 2018 - 2030 (USD Billion)
7.5.6 Powders
7.5.6.1 Powders market estimates and forecast, 2018 - 2030 (USD Billion)
7.5.7 Others
7.5.7.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 8 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Therapy Area, 2018 - 2030 (USD Billion)
8.1 Definition and Scope
8.2 Therapy Area Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Therapy Area, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Cardiovascular Diseases
8.5.1.1 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
8.5.2 Pain
8.5.2.1 Pain market estimates and forecast, 2018 - 2030 (USD Billion)
8.5.3 Diabetes
8.5.3.1 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
8.5.4 Cancer
8.5.4.1 Cancer market estimates and forecast, 2018 - 2030 (USD Billion)
8.5.5 Respiratory Diseases
8.5.5.1 Respiratory diseases market estimates and forecast, 2018 - 2030 (USD Billion)
8.5.6 Others
8.5.6.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 9 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Prescription Requirements, 2018 - 2030 (USD Billion)
9.1 Definition and Scope
9.2 Prescription Requirements Market Share Analysis, 2022 & 2030
9.3 Segment Dashboard
9.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Prescription Requirements, 2018 to 2030
9.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
9.5.1 Prescription Medicines
9.5.1.1 Prescription medicines market estimates and forecast, 2018 - 2030 (USD Billion)
9.5.2 Over - the - counter (OTC) Medicines
9.5.2.1 Over - the - counter (OTC) medicines market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 10 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Age Type, 2018 - 2030 (USD Billion)
10.1 Definition and Scope
10.2 Age Type Market Share Analysis, 2022 & 2030
10.3 Segment Dashboard
10.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Age Type, 2018 to 2030
10.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
10.5.1 Children & Adolescents
10.5.1.1 Children & adolescents market estimates and forecast, 2018 - 2030 (USD Billion)
10.5.2 Adults
10.5.2.1 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
10.5.3 Geriatric
10.5.3.1 Geriatric market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 11 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Sales Channel, 2018 - 2030 (USD Billion)
11.1 Definition and Scope
11.2 Sales Channel Market Share Analysis, 2022 & 2030
11.3 Segment Dashboard
11.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Sales Channel, 2018 to 2030
11.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
11.5.1 Retail
11.5.1.1 Retail market estimates and forecast, 2018 - 2030 (USD Billion)
11.5.2 Non - retail
11.5.2.1 Non - retail market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 12 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Region, 2018 - 2030 (USD Billion)
12.1 Definition & Scope
12.2 Regional Market Share Analysis, 2022 & 2030
12.3 Regional Market Dashboard
12.4 Regional Market Snapshot
12.5 SWOT Analysis
12.5.1 U.S.
12.5.2 Europe
12.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
12.6.1 U.S.
12.6.1.1 Key Country Dynamics
12.6.1.2 Competitive Scenario
12.6.1.3 Regulatory Framework
12.6.1.4 Reimbursement Scenario
12.6.1.5 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2 Europe
12.6.2.1 Europe pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
12.6.2.2 U.K.
12.6.2.2.1 Key Country Dynamics
12.6.2.2.2 Competitive Scenario
12.6.2.2.3 Regulatory Framework
12.6.2.2.4 Reimbursement Scenario
12.6.2.2.5 U.K. pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2.3 Germany
12.6.2.3.1 Key Country Dynamics
12.6.2.3.2 Competitive Scenario
12.6.2.3.3 Regulatory Framework
12.6.2.3.4 Reimbursement Scenario
12.6.2.3.5 Germany pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2.4 Spain
12.6.2.4.1 Key Country Dynamics
12.6.2.4.2 Competitive Scenario
12.6.2.4.3 Regulatory Framework
12.6.2.4.4 Reimbursement Scenario
12.6.2.4.5 Spain pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2.5 France
12.6.2.5.1 Key Country Dynamics
12.6.2.5.2 Competitive Scenario
12.6.2.5.3 Regulatory Framework
12.6.2.5.4 Reimbursement Scenario
12.6.2.5.5 France pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2.6 Italy
12.6.2.6.1 Key Country Dynamics
12.6.2.6.2 Competitive Scenario
12.6.2.6.3 Regulatory Framework
12.6.2.6.4 Reimbursement Scenario
12.6.2.6.5 Italy pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2.7 Denmark
12.6.2.7.1 Key Country Dynamics
12.6.2.7.2 Competitive Scenario
12.6.2.7.3 Regulatory Framework
12.6.2.7.4 Reimbursement Scenario
12.6.2.7.5 Denmark pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2.8 Sweden
12.6.2.8.1 Key Country Dynamics
12.6.2.8.2 Competitive Scenario
12.6.2.8.3 Regulatory Framework
12.6.2.8.4 Reimbursement Scenario
12.6.2.8.5 Sweden pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
12.6.2.9 Norway
12.6.2.9.1 Key Country Dynamics
12.6.2.9.2 Competitive Scenario
12.6.2.9.3 Regulatory Framework
12.6.2.9.4 Reimbursement Scenario
12.6.2.9.5 Norway pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 13 U.S. & Europe Pharmaceutical Manufacturing Market - Competitive Analysis
13.1 Recent Developments & Impact Analysis, by Key Market Participants
13.1.1 Ansoff matrix
13.1.2 Heat map analysis
13.1.3 Major Deals and Strategic Alliances Analysis
13.1.3.1 Joint Ventures
13.1.3.2 Licensing Agreements
13.1.3.3 Product Launches
13.1.3.4 Conferences and Campaigns
13.2 Company Categorization
13.2.1 Innovators
13.2.2 Market Leaders
13.3 Vendor Landscape
13.3.1 List of key distributors and channel partners
13.3.2 Key customers
13.4 Public Companies
13.4.1 Competitive Dashboard Analysis
13.4.1.1 Market Differentiators
13.5 Private Companies
13.5.1 List of key emerging companies
13.6 Company Profiles
13.6.1 AbbVie Inc
13.6.1.1 Company overview
13.6.1.2 Financial performance
13.6.1.3 Product benchmarking
13.6.1.4 Strategic Initiatives
13.6.2 Pfizer Inc.
13.6.2.1 Company overview
13.6.2.2 Financial performance
13.6.2.3 Product benchmarking
13.6.2.4 Strategic Initiatives
13.6.3 Novartis AG
13.6.3.1 Company overview
13.6.3.2 Financial performance
13.6.3.3 Product benchmarking
13.6.3.4 Strategic Initiatives
13.6.4 F. Hoffmann - La Roche Ltd
13.6.4.1 Company overview
13.6.4.2 Financial performance
13.6.4.3 Product benchmarking
13.6.4.4 Strategic Initiatives
13.6.5 Merck & Co., Inc.
13.6.5.1 Company overview
13.6.5.2 Financial performance
13.6.5.3 Product benchmarking
13.6.5.4 Strategic Initiatives
13.6.6 Johnson & Johnson Services, Inc.
13.6.6.1 Company overview
13.6.6.2 Financial performance
13.6.6.3 Product benchmarking
13.6.6.4 Strategic Initiatives
13.6.7 GSK plc
13.6.7.1 Company overview
13.6.7.2 Financial performance
13.6.7.3 Product benchmarking
13.6.7.4 Strategic initiatives
13.6.8 Sanofi
13.6.8.1 Company overview
13.6.8.2 Financial performance
13.6.8.3 Product benchmarking
13.6.8.4 Strategic initiatives
13.6.9 Lonza
13.6.9.1 Company overview
13.6.9.2 Financial performance
13.6.9.3 Product benchmarking
13.6.9.4 Strategic initiatives
13.6.10 Samsung Biologics
13.6.10.1 Company overview
13.6.10.2 Financial performance
13.6.10.3 Product benchmarking
13.6.10.4 Strategic initiatives
13.6.11 Lilly
13.6.11.1 Company overview
13.6.11.2 Financial performance
13.6.11.3 Product benchmarking
13.6.11.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 U.S. & Europe Pharmaceutical Manufacturing Market, By Region, 2018 - 2030 (USD Billion)
Table 5 U.S. & Europe Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 6 U.S. & Europe Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 7 U.S. & Europe Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 8 U.S. & Europe Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 9 U.S. & Europe Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 10 U.S. & Europe Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 11 U.S. & Europe Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 12 U.S. & Europe Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 13 U.S. Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 14 U.S. Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 15 U.S. Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 16 U.S. Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 17 U.S. Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 18 U.S. Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 19 U.S. Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 20 U.S. Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 21 Europe Pharmaceutical Manufacturing Market, By Country, 2018 - 2030 (USD Billion)
Table 22 Europe Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 23 Europe Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 24 Europe Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 25 Europe Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 26 Europe Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 27 Europe Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 28 Europe Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 29 Europe Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 30 Germany Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 31 Germany Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 32 Germany Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 33 Germany Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 34 Germany Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 35 Germany Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 36 Germany Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 37 Germany Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 38 U.K. Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 39 U.K. Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 40 U.K. Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 41 U.K. Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 42 U.K. Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 43 U.K. Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 44 U.K. Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 45 U.K. Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 46 France Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 47 France Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 48 France Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 49 France Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 50 France Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 51 France Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 52 France Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 53 France Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 54 Italy Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 55 Italy Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 56 Italy Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 57 Italy Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 58 Italy Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 59 Italy Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 60 Italy Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 61 Italy Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 62 Spain Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 63 Spain Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 64 Spain Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 65 Spain Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 66 Spain Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 67 Spain Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 68 Spain Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 69 Spain Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 70 Norway Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 71 Norway Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 72 Norway Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 73 Norway Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 74 Norway Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 75 Norway Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 76 Norway Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 77 Norway Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 78 Denmark Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 79 Denmark Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 80 Denmark Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 81 Denmark Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 82 Denmark Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 83 Denmark Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 84 Denmark Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 85 Denmark Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 86 Sweden Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 87 Sweden Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 88 Sweden Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 89 Sweden Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 90 Sweden Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 91 Sweden Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 92 Sweden Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 93 Sweden Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 U.S. & Europe pharmaceutical manufacturing market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 U.S. & Europe pharmaceutical manufacturing market: Product Type movement analysis
Fig. 17 U.S. & Europe pharmaceutical manufacturing market: Product Type segment dashboard
Fig. 18 U.S. & Europe pharmaceutical manufacturing market Product Type outlook: Key takeaways
Fig. 19 Small molecule market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Large molecule market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Vaccines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Cell & gene therapy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 U.S. & Europe pharmaceutical manufacturing market: Drug development type movement analysis
Fig. 26 U.S. & Europe pharmaceutical manufacturing market: Drug development type segment dashboard
Fig. 27 U.S. & Europe pharmaceutical manufacturing market Drug development type outlook: Key takeaways
Fig. 28 Outsource market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Outsource market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 U.S. & Europe pharmaceutical manufacturing market: Route of administration movement analysis
Fig. 31 U.S. & Europe pharmaceutical manufacturing market: Route of administration segment dashboard
Fig. 32 U.S. & Europe pharmaceutical manufacturing market Route of administration outlook: Key takeaways
Fig. 33 Oral market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Topical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Parenteral market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Inhalations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Inhalations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 U.S. & Europe pharmaceutical manufacturing market: Formulation movement analysis
Fig. 39 U.S. & Europe pharmaceutical manufacturing market: Formulation segment dashboard
Fig. 40 U.S. & Europe pharmaceutical manufacturing market Formulation outlook: Key takeaways
Fig. 41 Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 Capsules market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Injectables market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 Sprays market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 Suspensions market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Powders market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 U.S. & Europe pharmaceutical manufacturing market: Therapy area movement analysis
Fig. 49 U.S. & Europe pharmaceutical manufacturing market: Therapy area segment dashboard
Fig. 50 U.S. & Europe pharmaceutical manufacturing market Therapy area outlook: Key takeaways
Fig. 51 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 Pain market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 Cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 Respiratory diseases market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 U.S. & Europe pharmaceutical manufacturing market: Prescription requirements movement analysis
Fig. 58 U.S. & Europe pharmaceutical manufacturing market: Prescription requirements segment dashboard
Fig. 59 U.S. & Europe pharmaceutical manufacturing market Prescription requirements outlook: Key takeaways
Fig. 60 Prescription medicines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Over-the-counter (OTC) medicines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 62 U.S. & Europe pharmaceutical manufacturing market: Age type movement analysis
Fig. 63 U.S. & Europe pharmaceutical manufacturing market: Age type segment dashboard
Fig. 64 U.S. & Europe pharmaceutical manufacturing market Age type outlook: Key takeaways
Fig. 65 Children & adolescents market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 66 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 67 Geriatric market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 68 U.S. & Europe pharmaceutical manufacturing market: Sales channel movement analysis
Fig. 69 U.S. & Europe pharmaceutical manufacturing market: Sales channel segment dashboard
Fig. 70 U.S. & Europe pharmaceutical manufacturing market Sales channel outlook: Key takeaways
Fig. 71 Retail market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 72 Non-retail market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 73 Regional outlook, 2022 & 2030
Fig. 74 Regional market dashboard
Fig. 75 Regional market place: Key takeaways
Fig. 76 U.S, SWOT
Fig. 77 Europe, SWOT
Fig. 78 U.S.
Fig. 79 U.S. pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 80 Europe
Fig. 81 Europe pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 82 U.K.
Fig. 83 U.K. pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 84 Germany
Fig. 85 Germany pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 86 Spain
Fig. 87 Spain pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 88 France
Fig. 89 France pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 90 Italy
Fig. 91 Italy pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 92 Denmark
Fig. 93 Denmark pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 94 Norway
Fig. 95 Norway pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 96 Sweden
Fig. 97 Sweden pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 98 Ansoff Matrix
Fig. 99 Heat map analysis
Fig. 100 Market differentiators
Companies Mentioned
- AbbVie Inc
- Pfizer Inc.
- Novartis AG
- F. Hoffmann - La Roche Ltd
- Merck & Co., Inc.
- Johnson & Johnson Services, Inc.
- GSK plc
- Sanofi
- Lonza
- Samsung Biologics
- Lilly
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | January 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 412.5 Billion |
| Forecasted Market Value ( USD | $ 641.22 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Europe, United States |
| No. of Companies Mentioned | 11 |
